story of the week
Long-Term Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma
J. Clin. Oncol 2020 Sep 30;[EPub Ahead of Print], C Robert, GV Long, B Brady, C Dutriaux, AM Di Giacomo, L Mortier, P Rutkowski, JC Hassel, CM McNeil, EA Kalinka, C Lebbé, J Charles, MM Hernberg, KJ Savage, V Chiarion-Sileni, C Mihalcioiu, C Mauch, A Arance, F Cognetti, L Ny, H Schmidt, D Schadendorf, H Gogas, J Zoco, S Re, PA Ascierto, V AtkinsonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.